2022.L14.B – Apheresis, Ozone, and Other Therapies

The Role for Apheresis, Ozone, and other Therapies in Refractory Cases

Lecture abstract:

My presentation will focus on the three primary mechanisms of damage identified as the cause of the cascade of progressive and debilitating symptoms in our long COVID patients, whether from contracting the virus and/or from the vaccines. I will then review three of the five modalities we have been using that have proven remarkably effective. These include IV ozone therapy, EBOO/F, and IV therapies listed above (such as PDT), the majority of which effectively target mitochondrial health. These, together with stem cells and hyperbaric oxygen, have resulted in a speedy and complete recovery for approximately 70% of our patients. The rest, though not yet optimally recovered, have achieved at least sufficient functional recovery to “re-engage” in the full range of daily activities. Of course, we continue to search for more effective treatments for them.

About the Speaker

After completing undergraduate studies in Biological Sciences at the University of California, San Diego, followed by pioneering post-graduate work in Underwater Marine Biology Research at Scripps Institute of Oceanography, Asher Milgrom received a full scholarship to attend an MD/PhD program at the University of Chicago, studying Neuro-Biochemistry.

At the very end of his training, he experienced a near-death experience due to a rare brain infection that rendered him comatose. Miraculously, Dr. Milgrom survived completely intact and, having “touched the face of God and lived,” felt reborn with a transformed perspective on life. Consequently, upon recovering, he realized the daily routine of clinical medicine was insufficient to satiate his creative hunger and thus elected to expand his studies to encompass Biomedical Sciences. He has since been focusing on the development of new sciences and clinical protocols, now defined as “Integrative and Regenerative” medicine.

Together with his wife, Dr. Alice Pien, Dr. Milgrom launched AMA Regenerative Medicine & Skincare in 1999. As the company’s Chief Science Officer, Dr. Milgrom focuses on developing ‘what’s next,’ while Dr. Pien, as Chief Medical Officer, focuses on perfecting current protocols.

Their pioneering work includes holistic, “multiple-modality” clinical protocols that engage and enhance inherent physiological processes, rather than invasive protocols with all their attendant complications and dangers. Areas of specialization include: laser medicine, high potency IV therapy, from simple vitamins to sophisticated combinations of peptides and photosensitizing compounds (such as Methylene Blue, etc.), to acupuncture, hyperbaric oxygen treatments, PhotoDynamic Biomodulation (PDT) activated by a synergistic combination of intravascular and cutaneous lasers, a variety of Ozone therapies, Apheresis (EBOO/F), Hyperbaric Oxygen therapy, full body cryotherapy, and a variety of stem cell protocols, to name just a few.

Dr Asher Milgrom

PhD
CEO, Chief Scientist
AMA Regenerative Medicine & Skincare Inc.

Lecture Downloads

Share this Lesson
We use cookies on this site to enhance your user experience. By clicking the Accept button, you agree to us doing so. Read our Privacy Policy ACCEPT